The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...

A D.C. drugmaker is fighting the FDA on multiple fronts, from trying protect its intellectual property from generic ...

The US FDA has warned Sanofi about deviations from cGMP for active pharmaceutical ingredients at their Genzyme manufacturing plant.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Inability to provide accurate and timely diagnosis is one of the major contributors to the misuse and overuse of ...

INDIANAPOLIS — The state of Indiana is suing two of the world's biggest drug companies over the price of EpiPens. Attorney General Todd Rokita claims that Mylan and Pfizer have conspired to increase ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

United Kingdom, 15 th January 2025: Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as ...

The drug was approved by the FDA in August 2024 and is expected to reach the US market in the first quarter of 2025. A supplemental NDA has been submitted for Incyte’s Opzelura cream, which has the ...